Ellison Mark Jason Heath

CIK 00017819821 companySANTA MONICA, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001781982

Recent Transactions

21 trades

Disposition to Issuer
OPIANT PHARMACEUTICALS, INC.
Common Stock
2023-03-02−7,200→ 0 total
Disposition to Issuer
OPIANT PHARMACEUTICALS, INC.
Common Stock
2023-03-02$20.00/sh−2,000→ 0 total
Disposition to Issuer
OPIANT PHARMACEUTICALS, INC.
Stock Option (right to buy)
2023-03-02−10,750→ 0 total
Disposition to Issuer
OPIANT PHARMACEUTICALS, INC.
Common Stock
2023-03-02−8,250→ 0 total
Disposition to Issuer
OPIANT PHARMACEUTICALS, INC.
Common Stock
2023-03-02$20.00/sh−7,015→ 11,736 total
Disposition to Issuer
OPIANT PHARMACEUTICALS, INC.
Common Stock
2023-03-02$20.00/sh−11,736→ 0 total
Disposition to Issuer
OPIANT PHARMACEUTICALS, INC.
Common Stock
2023-03-02$20.00/sh−9,680→ 0 total
Award
OPIANT PHARMACEUTICALS, INC.
Common Stock
2023-03-02+2,000→ 2,000 total
Sale
OPIANT PHARMACEUTICALS, INC.
Common Stock
2023-01-27$20.26/sh−610→ 18,751 total
Sale
OPIANT PHARMACEUTICALS, INC.
Common Stock
2023-01-09$20.20/sh−469→ 19,361 total
Sale
OPIANT PHARMACEUTICALS, INC.
Common Stock
2023-01-05$20.20/sh−1,806→ 19,830 total
Award
OPIANT PHARMACEUTICALS, INC.
Common Stock
2022-06-27+2,000→ 21,636 total
Award
OPIANT PHARMACEUTICALS, INC.
Common Stock
2022-01-04+12,000→ 19,636 total
Award
OPIANT PHARMACEUTICALS, INC.
Common Stock
2021-01-26+2,236→ 2,236 total
Award
OPIANT PHARMACEUTICALS, INC.
Common Stock
2021-01-26+5,400→ 7,636 total
Award
OPIANT PHARMACEUTICALS, INC.
Stock Option (right to buy)
2021-01-26+10,750→ 10,750 total
Award
OPIANT PHARMACEUTICALS, INC.
Common Stock
2020-01-07+4,150→ 9,680 total
Award
OPIANT PHARMACEUTICALS, INC.
Common Stock
2020-01-07+8,250→ 8,250 total
Tax Payment
OPIANT PHARMACEUTICALS, INC.
Common Stock
2019-07-29$12.26/sh−24,470→ 5,530 total
Exercise/Conversion
OPIANT PHARMACEUTICALS, INC.
Common Stock
2019-07-29$10.00/sh+30,000→ 30,000 total
Exercise/Conversion
OPIANT PHARMACEUTICALS, INC.
Common Stock
2019-07-29−30,000→ 0 total

Companies

OPIANT PHARMACEUTICALS, INC.
UK Managing Director

Recent Filings

Address

201 SANTA MONICA BLVD

SANTA MONICA, CA, 90401

View on SEC.gov